stars 1 stars 2 stars 3

Ares Genetics - an OpGen Group Company - is developing DNA-based infectious disease services and solutions for drug response prediction to improve the way antimicrobial resistant (AMR) infections are diagnosed, and prevented or treated. Our innovative AI-powered and Machine Learning (ML) driven approach leverages the extensive, curated database ARESdb to comprehensively detect and determine the genetic profile of pathogens. Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy. Imprint: https://www.ares-genetics.com/imprint Please follow OpGen, our parent company, for updates.

Ares Genetics Questions

The Ares Genetics annual revenue was $1 million in 2026.

Johannes Weinberger is the Director R&D NGS of Ares Genetics.

2 people are employed at Ares Genetics.

Ares Genetics is based in Kien, Upper Austria.

The NAICS codes for Ares Genetics are [541, 5417, 54, 54171, 541713].

The SIC codes for Ares Genetics are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users